Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban pharmacokinetics in elderly patients with non-valvular atrial fibrillation
ChiCTR-OPN-15005948Phase 4Recruiting
- Sponsor
- Zhejiang Hospital
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of rivaroxaban in Atrial fibrillation (AFib) (2 arms), sponsored by Zhejiang Hospital. Primary endpoint: Plasma drug concentration. Started Feb 2015; status: recruiting.
02
Drugs
rivaroxaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on ChiCTR-OPN-15005948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-15005948.